Profil
Charbel Haber is currently the Senior Vice President-Regulatory Affairs at Moderna, Inc. He was previously the VP-Global Safety & Regulatory Sciences at Biogen, Inc. from 2017 to 2020.
Prior to that, he worked at EMD Serono, Inc. as the Head-Regulatory Affairs Immunology & Neurology.
Aktive Positionen von Charbel Haber
| Unternehmen | Position | Beginn |
|---|---|---|
| MODERNA, INC. | General Counsel | 21.04.2020 |
Ehemalige bekannte Positionen von Charbel Haber
| Unternehmen | Position | Ende |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01.03.2020 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| MODERNA, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
